IBT
IONS icon

International Biotechnology Trust’s Ionis Pharmaceuticals IONS Stock Holding History

International Biotechnology Trust’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.95M Hold
43,000
– – 0.66% 41
2023
Q2 		$1.76M Hold
43,000
– – 0.54% 38
2023
Q1 		$1.54M Buy
+43,000
New +$1.61M 0.43% 47
2022
Q3 		– Sell
-1,703
Closed -$46.1K – 76
2022
Q2 		$46.1K Sell
1,703
-152,385
-99% -$5.75M 0.48% 45
2022
Q1 		$3.3M Sell
154,088
-201,000
-57% -$6.58M 0.74% 32
2021
Q4 		$10.8M Buy
355,088
+310,307
+693% +$9.77M 2.41% 15
2021
Q3 		$1.5M Sell
44,781
-137,000
-75% -$5.16M 0.36% 48
2021
Q2 		$7.25M Sell
181,781
-152,000
-46% -$5.95M 1.91% 17
2021
Q1 		$15M Buy
333,781
+256,000
+329% +$14.3M 3.97% 10
2020
Q4 		$4.4M Buy
77,781
+38,000
+96% +$1.89M 1.2% 22
2020
Q3 		$1.89M Hold
39,781
– – 0.61% 29
2020
Q2 		$2.36M Sell
39,781
-14,000
-26% -$779K 0.79% 24
2020
Q1 		$2.54M Hold
53,781
– – 1.16% 20
2019
Q4 		$3.25M Buy
53,781
+7,600
+16% +$453K 1.17% 23
2019
Q3 		$2.77M Sell
46,181
-36,600
-44% -$2.39M 1.28% 19
2019
Q2 		$5.32M Buy
82,781
+35,000
+73% +$2.47M 1.97% 18
2019
Q1 		$3.88M Buy
47,781
+7,781
+19% +$502K 1.43% 25
2018
Q4 		$1.7M Sell
40,000
-11,500
-22% -$587K 1.05% 26
2018
Q3 		$2.04M Sell
51,500
-75,000
-59% -$3.52M 0.97% 31
2018
Q2 		$5.27M Hold
126,500
– – 2.02% 20
2018
Q1 		$5.58M Buy
126,500
+75,000
+146% +$3.81M 2.18% 17
2017
Q4 		$2.59M Hold
51,500
– – 0.91% 32
2017
Q3 		$2.61M Hold
51,500
– – 1.02% 32
2017
Q2 		$2.62M Hold
51,500
– – 1% 33
2017
Q1 		$2.07M Buy
+51,500
New +$2.31M 0.79% 32

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

International Biotechnology Trust's IONS Position: Q3 2023 in Review

International Biotechnology Trust held its Ionis Pharmaceuticals (IONS) position steady in Q3 2023 at 43,000 shares worth $1.95M. The position accounts for 0.66% of the portfolio, ranked #41.

International Biotechnology Trust first reported a position in IONS in Q1 2017 and has held it in 25 quarters since. The position peaked at $15M in Q1 2021. 310 funds tracked by Wall St. Rank hold IONS as of Q3 2023.

  • International Biotechnology Trust held 43,000 shares of Ionis Pharmaceuticals worth $1.95M as of Q3 2023.
  • International Biotechnology Trust left its Ionis Pharmaceuticals share count unchanged in Q3 2023.
  • Ionis Pharmaceuticals made up 0.66% of International Biotechnology Trust's portfolio in Q3 2023, its #41 holding.
  • International Biotechnology Trust first reported a position in Ionis Pharmaceuticals in Q1 2017 and has held it in 25 quarters since.
  • International Biotechnology Trust's Ionis Pharmaceuticals position peaked at $15M in Q1 2021.
  • 310 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.